Progenitor (PGEN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Progenitor (PGEN)

PGEN 4.140

+2.2%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve Lokness who wrote (27)	2/24/1998 10:05:00 AM
From: Czechsinthemail	Read Replies (2) of 106

Steve, I agree the stock looks undervalued. Given the small trading volume, it can be moved dramatically by any news. Right now, I suspect the stock's recent weakness may be reflecting formerly restricted shares hitting the market. That's kind of routine following IPO's, and IMO represents a good buying opportunity on temporary price weakness. Regarding news, there was a story on National Public Radio this morning about angiogenesis therapy, involving the introduction of a gene or protein into heart muscle to generate new blood vessels and improved oxygenation for the heart. Apparently, there is a lot of research going on and an article in the journal, Circulation. Since PGEN is expected to announce a partnership around its angiogenesis gene soon, the news that this is a hot research area would be a definite positive. Baird

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next